Evidence map›Paper›PMID 27216620›Full record

ArticleNeurochemical research2016

Blue Light Action on Mitochondria Leads to Cell Death by Necroptosis.

Susana Del Olmo-Aguado, Claudia Núñez-Álvarez, Neville N Osborne

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Therapeutic Potential ofAntioxidants (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Review
  13. Review
  14. Blue-Light-Blocking Lenses Ameliorate Structural Alterations in the Rodent Hippocampus.International journal of environmental research and public health · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Susana Del Olmo-AguadoFundación de Investigación Oftalmológica, Avda. Doctores Fernández-Vega 34, 33012, Oviedo, Asturias, Spain.
Claudia Núñez-ÁlvarezFundación de Investigación Oftalmológica, Avda. Doctores Fernández-Vega 34, 33012, Oviedo, Asturias, Spain.
Neville N OsborneFundación de Investigación Oftalmológica, Avda. Doctores Fernández-Vega 34, 33012, Oviedo, Asturias, Spain. Neville.osborne@eye.ox.ac.uk.
Fernández-Vega Ophthalmological Institute · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blue light impinging on the many mitochondria associated with retinal ganglion cells (RGCs) in situ has the potential of eliciting necroptosis through an action on RIP1/RIP3 to stimulate RGC death in diseases like glaucoma and diabetic retinopathy. Cells in culture die when exposed to blue light. The death process is mitochondria-dependent and is known to involve a decrease in the production of ATP, a generation of ROS, the activation of poly-(ADP-ribose) polymerase, the stimulation of apoptosis-inducing factor (AIF) as well as the up-regulation of heme-oxygenase-1 (HO-1). Our present results show that blue light-induced activation of AIF is not directly linked with the stimulation of RIP1/RIP3. Down-regulation of RIP1/RIP3 did not influence AIF. AIF activation therefore appears to enhance the rate of necroptosis by a direct action on DNA breakdown, the end stage of necroptosis. This implies that silencing of AIF mRNA may provide a degree of protection to blue light insult. Also, necrostatin-1 attenuated an increased turnover of HO-1 mRNA caused by blue light to suggest an indirect inhibition of necroptosis, caused by the action of necrostatin-1 on RIP1/RIP3 to reduce oxidative stress. This is supported by the finding that gene silencing of RIP1 and RIP3 has no effect on HO-1. We therefore conclude that inhibitors of RIP kinase might be more specific than necrostatin-1 as a neuroprotective agent to blunt solely necroptosis caused by blue light.

Indexed as

AnimalsApoptosisCell SurvivalLightMiceMitochondriaNecrosisOxidative StressRetinal Ganglion CellsUp-RegulationApoptosis-inducing factor (AIF)Blue lightHeme-oxygenase-1 (HO-1)MitochondriaNecroptosisProtein kinase-1 (RIP1) and 3 (RIP3)

Identifiers

PMID27216620
OpenAlexW2396811347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.